AMENDMENT NO.4 TO THE INVESTMENT AGREEMENTThe Investment Agreement • December 4th, 2023 • SAIF Partners IV L.P. • Pharmaceutical preparations
This AMENDMENT NO.4 TO THE INVESTMENT AGREEMENT (this “Amendment”) dated as of December 1, 2023 is made by and between (i) SAIF PARTNERS IV L.P., an exempted limited partnership registered and existing under the Laws of the Cayman Islands (the “Seller”) and (ii) YZ Healthcare L.P., an exempted partnership established under the Laws of the Cayman Islands (the “Buyer”). The Buyer and the Seller are hereinafter referred to as the “Parties” and each a “Party”.
INVESTMENT AGREEMENTInvestment Agreement • December 12th, 2022 • SAIF Partners IV L.P. • Pharmaceutical preparations • New York
This INVESTMENT AGREEMENT (this “Agreement”) dated as of November 23, 2022 is made by and between (i) SAIF PARTNERS IV L.P., an exempted limited partnership registered and existing under the Laws of the Cayman Islands (the “Seller”) and (ii) YZ Healthcare L.P., an exempted partnership established under the Laws of the Cayman Islands (the “Buyer”). The Buyer and the Seller are hereinafter referred to as the “Parties” and each a “Party”.
AMENDMENT NO.1 TO THE INVESTMENT AGREEMENTThe Investment Agreement • March 15th, 2023 • SAIF Partners IV L.P. • Pharmaceutical preparations
This AMENDMENT NO.1 TO THE INVESTMENT AGREEMENT (this “Amendment”) dated as of March 15, 2023 is made by and between (i) SAIF PARTNERS IV L.P., an exempted limited partnership registered and existing under the Laws of the Cayman Islands (the “Seller”) and (ii) YZ Healthcare L.P., an exempted partnership established under the Laws of the Cayman Islands (the “Buyer”). The Buyer and the Seller are hereinafter referred to as the “Parties” and each a “Party”.
Joint Filing AgreementJoint Filing Agreement • July 25th, 2012 • SAIF Partners IV L.P. • Services-motion picture & video tape distribution
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the American Depositary Shares representing Ordinary Shares, par value US$0.0005 per share, of Bona Film Group Limited, a Cayman Islands company, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which, taken together, shall constitute one and the same instrument.
Joint Filing AgreementJoint Filing Agreement • November 15th, 2010 • SAIF Partners IV L.P. • Pharmaceutical preparations
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the common shares, par value US$0.001, of Sinovac Biotech Ltd., and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which, taken together, shall constitute one and the same instrument.
Joint Filing AgreementJoint Filing Agreement • June 27th, 2017 • SAIF Partners IV L.P. • Pharmaceutical preparations
This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
Joint Filing AgreementJoint Filing Agreement • February 2nd, 2016 • SAIF Partners IV L.P. • Pharmaceutical preparations
This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
AMENDMENT NO.2 TO THE INVESTMENT AGREEMENTThe Investment Agreement • May 25th, 2023 • SAIF Partners IV L.P. • Pharmaceutical preparations
This AMENDMENT NO.2 TO THE INVESTMENT AGREEMENT (this “Amendment”) dated as of May 25, 2023 is made by and between (i) SAIF PARTNERS IV L.P., an exempted limited partnership registered and existing under the Laws of the Cayman Islands (the “Seller”) and (ii) YZ Healthcare L.P., an exempted partnership established under the Laws of the Cayman Islands (the “Buyer”). The Buyer and the Seller are hereinafter referred to as the “Parties” and each a “Party”.
ContractJoint Filing Agreement • May 31st, 2011 • SAIF Partners IV L.P. • Pharmaceutical preparations
In accordance with Rule 13d-1(k), promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the common shares, par value $0.001 per share, of Sinovac Biotech Ltd., and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
AMENDMENT NO.5 TO THE INVESTMENT AGREEMENTThe Investment Agreement • June 17th, 2024 • SAIF Partners IV L.P. • Pharmaceutical preparations
This AMENDMENT NO.5 TO THE INVESTMENT AGREEMENT (this “Amendment”) dated as of June 13, 2024 is made by and between (i) SAIF PARTNERS IV L.P., an exempted limited partnership registered and existing under the Laws of the Cayman Islands (the “Seller”) and (ii) YZ Healthcare L.P., an exempted partnership established under the Laws of the Cayman Islands (the “Buyer”). The Buyer and the Seller are hereinafter referred to as the “Parties” and each a “Party”.
